| Genetic meta-analysis of diagnosed Alzheimer¢s disease identifies new risk loci and implicates Aâ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2175 | 2019 |
| Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ... Nature genetics 49 (9), 1373-1384, 2017 | 902 | 2017 |
| Donanemab in early Alzheimer¢s disease MA Mintun, AC Lo, C Duggan Evans, AM Wessels, PA Ardayfio, ... New England Journal of Medicine 384 (18), 1691-1704, 2021 | 823 | 2021 |
| Identification of common variants associated with human hippocampal and intracranial volumes JL Stein, SE Medland, AA Vasquez, DP Hibar, RE Senstad, AM Winkler, ... Nature genetics 44 (5), 552-561, 2012 | 698 | 2012 |
| The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data PM Thompson, JL Stein, SE Medland, DP Hibar, AA Vasquez, ... Brain imaging and behavior 8, 153-182, 2014 | 664 | 2014 |
| Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps LG Apostolova, RA Dutton, ID Dinov, KM Hayashi, AW Toga, ... Archives of neurology 63 (5), 693-699, 2006 | 663 | 2006 |
| Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature LG Apostolova, JL Cummings Dementia and geriatric cognitive disorders 25 (2), 115-126, 2008 | 544 | 2008 |
| Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study JM Ringman, SA Frautschy, E Teng, AN Begum, J Bardens, M Beigi, ... Alzheimer's research & therapy 4, 1-8, 2012 | 508 | 2012 |
| Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial JR Sims, JA Zimmer, CD Evans, M Lu, P Ardayfio, JD Sparks, AM Wessels, ... Jama 330 (6), 512-527, 2023 | 385 | 2023 |
| Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease LG Apostolova, AE Green, S Babakchanian, KS Hwang, YY Chou, ... Alzheimer Disease & Associated Disorders 26 (1), 17-27, 2012 | 382 | 2012 |
| Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal LG Apostolova, L Mosconi, PM Thompson, AE Green, KS Hwang, ... Neurobiology of aging 31 (7), 1077-1088, 2010 | 333 | 2010 |
| Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ... Neurology 85 (14), 1240-1249, 2015 | 332 | 2015 |
| Alzheimer disease LG Apostolova Continuum: Lifelong Learning in Neurology 22 (2), 419-434, 2016 | 331 | 2016 |
| 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease LG Apostolova, ID Dinov, RA Dutton, KM Hayashi, AW Toga, ... Brain 129 (11), 2867-2873, 2006 | 327 | 2006 |
| New insights into atypical Alzheimer's disease in the era of biomarkers J Graff-Radford, KXX Yong, LG Apostolova, FH Bouwman, M Carrillo, ... The Lancet Neurology 20 (3), 222-234, 2021 | 297 | 2021 |
| Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations JM Ringman, J O¢Neill, D Geschwind, L Medina, LG Apostolova, ... Brain 130 (7), 1767-1776, 2007 | 297 | 2007 |
| Aducanumab: appropriate use recommendations J Cummings, P Aisen, LG Apostolova, A Atri, S Salloway, M Weiner The journal of prevention of Alzheimer's disease 8, 398-410, 2021 | 284 | 2021 |
| Comparison of AdaBoost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation JH Morra, Z Tu, LG Apostolova, AE Green, AW Toga, PM Thompson IEEE transactions on medical imaging 29 (1), 30-43, 2009 | 284 | 2009 |
| Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls JH Morra, Z Tu, LG Apostolova, AE Green, C Avedissian, SK Madsen, ... Neuroimage 45 (1), S3-S15, 2009 | 283 | 2009 |
| Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer¢s disease DA Wolk, BC Dickerson, Alzheimer¢s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 274 | 2010 |
